Short- and longevity outcome of cyclosporin rescue therapy in severe ulcerative colitis refractory to intravenous corticosteroid treatment
CsA may be a potent therapeutic option to induce remission in steroid-refractory, severely active UC, and its effectiveness may be enhanced by the concomitant use of immunomodulators, without compromising safety.
Authors
- Zoltán Szepes (ORCID: https://orcid.org/0000-0002-9466-8719)
- Anna Fábián (ORCID: https://orcid.org/0000-0002-0824-7476)
- Emese Ivány (ORCID: https://orcid.org/0000-0002-5535-8558)
- Renáta Bor (ORCID: https://orcid.org/0000-0001-9393-5240)
- Péter Bacsúr (ORCID: https://orcid.org/0000-0002-8534-0068)
- M Rutka
- Tamás Molnár (ORCID: https://orcid.org/0000-0002-4913-7599)
- Zsófia Bősze (ORCID: https://orcid.org/0009-0004-9262-9742)
- Klaudia Farkas (ORCID: https://orcid.org/0000-0003-0599-182X)
- B Farkas (ORCID: https://orcid.org/0009-0007-8816-0138)
- Anita Bálint
Institutions
- University of Szeged (HU)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1177/17562848251361054
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Szegedi Tudományegyetem
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- National Research, Development and Innovation Office